- Home
- ORMP vs NUCL Comparison
ORMP vs NUCL Comparison
Compare ORMP & NUCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORMP | NUCL |
|---|---|---|
| Founded | 2002 | 2023 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Metals and Minerals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 197.6M | 167.1M |
| IPO Year | 2010 | 2026 |
Fundamental Metrics
Financial Performance| Metric | ORMP | NUCL |
|---|---|---|
| Price | $4.20 | $5.27 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 151.9K | ★ 225.1K |
| Earning Date | 11-12-2026 | 10-13-2026 |
| Dividend Yield | ★ 6.00% | N/A |
| EPS Growth | ★ 412.50 | N/A |
| EPS | ★ 2.76 | N/A |
| Revenue | ★ $2,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $1.51 | ★ N/A |
| Revenue Growth | ★ 49.25 | N/A |
| 52 Week Low | $2.09 | $4.55 |
| 52 Week High | $5.47 | $14.22 |
Technical Indicators
Market Signals| Indicator | ORMP | NUCL |
|---|---|---|
| Relative Strength Index (RSI) | 35.04 | 28.45 |
| Support Level | $4.16 | $5.14 |
| Resistance Level | $4.22 | $6.45 |
| Average True Range (ATR) | 0.15 | 0.29 |
| MACD | -0.05 | -0.06 |
| Stochastic Oscillator | 10.26 | 4.72 |
Price Performance
Historical ComparisonAbout ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.
About NUCL Eagle Nuclear Energy Corp. Common stock
Eagle Nuclear Energy Corp is a next-generation nuclear energy company that seeks to combine domestic uranium exploration and development with proprietary small modular reactor (SMR) technology. It holds rights to the mineable, measured, and indicated uranium deposit in the United States, known as the Aurora Uranium Project, located in southeastern Oregon. The Aurora Uranium Project includes the Aurora deposit, with an estimated resource of 32.75 million pounds (Indicated) and 4.98 million pounds (Inferred) of near-surface uranium, and the adjacent Cordex zone.